Trial Site Detail

 

Drug:
IPI-504
Trial:
Study of IPI-504 in GIST patients following failure of at least imatinib and sunitinib
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Terminated

 

Cedars-Sinai Outpatient Cancer Center

8700 Beverly Blvd.     
Los Angeles , CA 90048
USA

 

Principal Investigator:
Charles Forscher
Contact:
Ginny Naessig 310-423-0721 virginia.naessig@cshs.org
Activation Status of this Site:
Closed
Notes about this Site:
Cedars-Sinai Outpatient Cancer Center Website:
http://apps.csmc.edu/SearchClinicalTrials/

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.